Dunad Therapeutics’ Post

View organization page for Dunad Therapeutics, graphic

4,180 followers

Dunad Therapeutics is thrilled to announce that CEO Pearl Huang has been selected as a finalist for the Lifetime Achievement Award at Biotech Week Boston 2023! The Lifetime Achievement Award recognizes an exceptional individual who has served the industry beyond the call of duty throughout a distinguished career. For the last 30 years Pearl Huang has been doing just that by applying her strong leadership, scientific and business insights to bring innovative therapies to patients in need.

  • No alternative text description for this image
Kal L.

Biotech Executive I Start-up Strategy and Operations I Builder

1y

Well- deserved. Congrats Pearl

Jordi Mata-Fink

Co-Founder and CEO at Gate Bioscience

1y

Wonderful news, Pearl, and very well deserved!

Tim Zheng

Chief Scientific Officer

1y

Congrats Pearl!!!

Bublu (Sarbani) Thakur-Weigold

Associate Director, Programs at ETH Zürich

1y

So richly deserved Pearl Huang

Congratulations, Pearl! Very exciting!

Geordon Frere

Postdoctoral Research Fellow, Chemical Proteomics | Harvard Medical School | PhD in Chemistry from the University of Toronto (NSERC CGS-D) | Medicinal Chemistry & Chemical Biology

1y

Congrats, Pearl!

Katie Fowler

Consultant | Biotechnology | Early-Stage | Private Equity & Venture Capital | Pharmaceuticals | Telemedicine | Technology |

1y

Congratulations Pearl!

Jay (Chih-Chieh) Wang

Data driven strategic scientist and group/project leader

1y

Congratulations Pearl!

Guang Liu

Senior Director, Cellular Assays at Kymera Therapeutics

1y

Congratulations Pearl!

Aubrey Watkins III, Ph.D., M.S.

Vice President, Corporate Development

1y

Congratulations Pearl!!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics